Brief: AnGes submits application for marketing approval for HGF gene therapy

AnGes

22/01/2018 02:48

Jan 22 (Reuters) - AnGes Inc  4563.T  : 
       
    * Says it submits application for marketing approval to 
Pharmaceuticals and Medical Devices Agency (PMDA) for HGF gene 
therapy for the treatment of critical limb ischemia (CLI) 
 
     
    Source text in Japanese: https://goo.gl/DKLSkV 
    Further company coverage: 4563.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724; 
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))